A Nationwide Experience With The Off ‐label Use of Interleukin‐1 Targeting Treatment in Familial Mediterranean Fever Patients

ConclusionAnti‐IL1 treatment is an effective alternative for controlling attacks and decreasing proteinuria in colchicine‐resistant FMF patients.This article is protected by copyright. All rights reserved.

Source: Arthritis Care and Research - October 9, 2017 Category: Rheumatology Authors: Servet Akar, P ınar Cetin, Umut Kalyoncu, Omer Karadag, Ismail Sari, Muhammed Cınar, Sedat Yilmaz, Ahmet Mesut Onat, Bunyamin Kisacik, Abdulsamet Erten, Ayse Balkarli, Orhan Kucuksahin, Sibel Yilmaz Oner, Soner Senel, Abdurrahman Tufan, Haner Direskenel Tags: Original Article Source Type: research